Le Lézard
Classified in: Health, Science and technology

Global Antibiotics Partnering Terms and Agreements 2010 to 2022 Provides Coverage on 300 Links to Online Copies of Actual Antibiotics Deals and Contract Documents - ResearchAndMarkets.com


The "Global Antibiotics Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering.

The Global Antibiotics Partnering Terms and Agreements 2010 to 2022 report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Antibiotics Partnering Terms and Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.

This report provides details of the latest antibiotics agreements announced in the healthcare sectors, covering:

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report contains over 300 links to online copies of actual antibiotics deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

For example, analyzing actual company deals and agreements allows assessment of the following:

The report also includes numerous tables and figures that illustrate the trends and activities in antibiotics partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of antibiotics technologies and products.

Report scope

Global Antibiotics Partnering Terms and Agreements 2010 to 2022 is intended to provide the reader with an in-depth understanding and access to antibiotics trends and the structure of deals entered into by leading companies worldwide.

Global Antibiotics Partnering Terms and Agreements 2010 to 2022 includes:

In Global Antibiotics Partnering Terms and Agreements 2010 to 2022, the available contracts are listed by:

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in antibiotics dealmaking

2.1. Introduction

2.2. Antibiotics partnering over the years

2.3. Most active antibiotics dealmakers

2.4. Antibiotics partnering by deal type

2.5. Antibiotics partnering by therapy area

2.6. Antibiotics partnering by industry sector

2.7. Deal terms for antibiotics partnering

2.7.1 Antibiotics partnering headline values

2.7.2 Antibiotics deal upfront payments

2.7.3 Antibiotics deal milestone payments

2.7.4 Antibiotics royalty rates

2.8. The anatomy of an antibiotics deal

2.8. a. Case study 1:

2.8.b. Case study 2:

2.8.c. Case study 3:

Chapter 3 - Leading antibiotics deals

3.1. Introduction

3.2. Top antibiotics deals by value

Chapter 4 - Most active antibiotics dealmakers

4.1. Introduction

4.2. Most active antibiotics dealmakers

4.3. Most active antibiotics partnering company profiles

Chapter 5 - Antibiotics contracts dealmaking directory

5.1. Introduction

5.2. Antibiotics contracts dealmaking directory

Chapter 6 - Antibiotics dealmaking by technology type

Appendices

Appendix 1 - Antibiotics deals by company A-Z

Appendix 2 - Antibiotics deals by stage of development

Appendix 3 - Antibiotics deals by deal type

Appendix 4 - Antibiotics deals by therapy area

Appendix 5 - Deal type definitions

Appendix 6 - Further reading on dealmaking

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/z6yqk4


These press releases may also interest you

at 10:07
Fresh Start Surgical Gifts has partnered with Sanford Health to expand their services and further their mission to transform the lives of children and teens forever. Fresh Start recently hosted free informational sessions on services offered in Sioux...

at 10:03
According to the Centers for Disease Control and Prevention (CDC), one in eight people living with HIV in the United States is undiagnosed, and more than one-third of all new HIV infections are transmitted by people who do not know they have HIV. HIV...

at 10:00
As per Zion Market Research study, The global connected healthcare market attained revenue growth of USD 51.49 billion in 2021 and is forecasted to reach nearly USD 296.55 billion by 2028, with a compound annual growth rate (CAGR) of approximately...

at 10:00
Ceruvia Lifesciences, a leading neurotransformational medicine biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug application for a Phase 2 clinical trial to determine...

at 10:00
Arzeda, the industry-leading Protein Design Companytm, announced today that it is collaborating with W. L. Gore & Associates, a global leader in advanced materials science, on research leveraging Arzeda's technology platform that economically and...

at 10:00
NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing a portfolio of disease-modifying therapeutic candidates to treat the devastating effects of stroke and traumatic brain injury (TBI), today reported data on its novel...



News published on 23 may 2022 at 07:20 and distributed by: